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ABSTRACT
KASHIWABARA, K., T. KIDOKORO, T. YANAOKA, S. F. BURNS, D. J. STENSEL, and M. MIYASHITA. Different Patterns of
Walking and Postprandial Triglycerides in Older Women. Med. Sci. Sports Exerc., Vol. 50, No. 1, pp. 79–87, 2018. Purpose: Although
a single bout of continuous exercise (Q30 min) reduces postprandial triglyceride (TG), little evidence is available regarding the
effect of multiple short (e10 min) bouts of exercise on postprandial TG in individuals at increased risk for cardiovascular diseases. This
study compared the effects of different patterns of walking on postprandial TG in postmenopausal, older women with hypertriglyc-
eridemia. Methods: Twelve inactive women (mean age T SD, 71 T 5 yr) with hypertriglyceridemia (fasting TG Q1.70 mmolILj1)
completed three, 1-d laboratory-based trials in a random order: 1) control, 2) continuous walking, and 3) multiple short bouts of walking.
On the control trial, participants sat in a chair for 8 h. For the walking trials, participants walked briskly in either one 30-min bout in the
morning (0900–0930 h) or twenty 90-s bouts over 8 h. Except for walking, both exercise trials mimicked the control trial. In each trial,
participants consumed a standardized breakfast (0800 h) and lunch (1100 h). Venous blood samples were collected in the fasted state and
at 2, 4, 6, and 8 h after breakfast. Results: The serum TG incremental area under the curve was 35% and 33% lower on the continuous
and multiple short bouts of walking trials than that on the control trial (8.2 T 3.1 vs 8.5 T 5.4 vs 12.7 T 5.8 mmol per 8 hILj1, respectively;
main effect of trial: effect size = 0.459, P = 0.001). Conclusions: Accumulating walking in short bouts limits postprandial TG in at-risk,
inactive older women with fasting hypertriglyceridemia. Key Words: POSTPRANDIAL TRIGLYCERIDE, HYPERTRIGLYC-
ERIDEMIA, WALKING, POSTMENOPAUSAL WOMEN, OLDER ADULTS
T
he most recent US recommendation for physical ac-
tivity, jointly published by the American College of
Sports Medicine and American Heart Association,
states that adults should accumulate moderate-intensity
physical activity for a minimum of 30 min for 5 d each week
(1). These recommendations are similar to those put forth by
the World Health Organization (2). Moreover, both sets of
recommendations include the caveat that activity can be ac-
cumulated throughout the day in a minimum of 10-min bouts
to attain the 30 min needed (1). Although the concept of
accumulation is embedded within these recommendations,
the US Physical Activity Guidelines Advisory Committee
Report in 2008 (3) highlighted that only ‘‘limited data’’ in-
dicated that accumulating activity in bouts of 8–10 min was
able to improve selected cardiovascular disease biomarkers
in a manner similar to that observed for the same volume of
continuous activity.
Elevated nonfasting triglyceride (TG) concentrations are a
causal risk factor for cardiovascular disease and all-cause
mortality in men and women (4,5). The effectiveness of
accumulating short bouts of activity to reduce concentra-
tions of postprandial TG has been addressed in previous ef-
ficacy studies (6–12) (for a review of these, see Refs. [13–15]).
Collectively, these studies have reported that accumulation
of physical activity in shorts bouts, lasting 1.5–10 min in
length, over a day confers a reduction in postprandial TG
that is comparable to, or greater than, a similar volume of
continuous activity (8–12). These findings have practical
implications for the general public because participation in
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accumulated activity may be easier to incorporate into a
daily schedule (16). Furthermore, a recent review has ad-
dressed that time spent in sedentary behavior, predominantly
prolonged sitting, is independently associated with all-cause
and cardiovascular disease mortality and cardiovascular disease
incidence (17), although very high levels of moderate-intensity
physical activity abolish this association (18). Laboratory-
based studies demonstrate that regular interruption of sed-
entary time with brief bouts of physical activity can lower
postprandial glucose (19–22) and insulin (21,22) and, in
some studies, postprandial TG (21). However, despite clear
evidence demonstrating that short durations of exercise ac-
cumulated in bouts of G10 min can reduce postprandial TG,
no studies have addressed this in physically inactive older
individuals at elevated risk for cardiovascular diseases. This
issue is important to address because TG excursions after
meals are often exaggerated in these individuals compared
with their healthy peers (23).
Thus, the purpose of the present study was to examine
postprandial TG concentrations in postmenopausal, older
women with hypertriglyceridemia after either 30 min of
continuous walking or 30 min of walking accumulated in
twenty, 1.5-min bouts performed throughout a single day.
Most previous studies have examined the delayed (next-day)
effects of accumulating exercise on postprandial TG, rather
than the same-day effects (24), partly because of the delayed
expression of lipoprotein lipase (LPL), which is responsible
for TG clearance from the circulation. However, some studies
(11,14,21), but not all (19,25), have shown that postprandial
TG can be reduced when activity is performed on the same
day. From the perspective of daily metabolic control, it may
be beneficial if reductions in postprandial TG occurred in
tandem with reductions in glucose and insulin, which have
been shown to occur in many studies (19–22). In addition,
we wanted to evaluate whether this protocol is effective in
reducing postprandial TG in at-risk individuals as it was
in our previous study of normolipidemic, postmenopausal
women (11).
METHODS
Participants. After approval from the institutional ethical
advisory committee, 12 Japanese postmenopausal women with
hypertriglyceridemia (fasting TG Q1.70 mmolILj1) gave writ-
ten informed consent to participate in this study. Exclusion
criteria for the studywere as follows: fasting TG G1.70mmolILj1,
current smoker, major illness, or physical problems (acute
or chronic) limiting the ability to perform low-intensity
physical activities. Initial information obtained via interview
and questionnaire also indicated that no participant met
current international public health guidelines for physical
activity (i.e., moderate-intensity physical activity for at least
150 minIwkj1 or vigorous-intensity physical activity for
75 minIwkj1 or an equivalent combination of moderate
and vigorous-intensity physical activity) (2). Nine women
possessed the E3/E3 apolipoprotein (apo) E phenotype, two
women possessed the E4/E3 apo E phenotype and one woman
possessed the E4/E4 apo E phenotype. The physical charac-
teristics of the participants (mean T SD) were as follows: age
of 70.5 T 4.6 yr, body mass index of 25.3 T 3.5 kgImj2, sys-
tolic blood pressure of 144 T 19 mm Hg, and diastolic blood
pressure of 85 T 11 mm Hg.
Anthropometry. Body mass was measured to the
nearest 0.1 kg using a digital scale (Inner Scan 50; Tanita
Corporation, Tokyo, Japan). Height was measured to the
nearest 0.1 cm using a wall-mounted stadiometer (YS-OA;
AS ONE Corporation, Osaka, Japan). Body mass index was
calculated as weight in kilograms divided by the square of
height in meters. Waist circumference was measured to the
nearest 0.1 cm at the level of the umbilicus using a flexi-
ble plastic tape. Arterial blood pressure was measured from
the right arm in a seated position by a standard mercury
sphygmomanometer (605P; Yagami Co Ltd, Yokohama,
Japan). Participants were seated on a chair for 5 min before
measurements. Two measurements were taken, and the mean
of these values was recorded.
Preliminary test. After a treadmill familiarization ses-
sion, each participant was asked to walk ‘‘briskly’’ on a
motorized treadmill (JOG NOW 700; Technogym, Milan,
Italy) for several minutes to determine their walking speed
for the main trial. ‘‘Brisk’’ walking was defined as feeling
slightly out of breath while walking but still able to hold
a conversation.
Standardization of diet and exercise. Participants
weighed and recorded all food and drink consumed the day
before each trial and refrained from drinking alcohol during
this period. Participants replicated their dietary intake from
the first trial in subsequent trials ensuring that meals were
standardized across trials. Food diaries were analyzed by a
registered dietitian to determine energy intake and macro-
nutrient content. In addition, the participants were asked to
remain inactive the day before each main trial. Participants
wore a uniaxial accelerometer (Lifecoder-EX; Suzuken Co
Ltd, Nagoya, Japan) to monitor daily activity during this
period. The accelerometer defined 11 levels of activity inten-
sity (0, 0.5, and 1–9), with 0 indicating the lowest intensity
and 9 being the highest intensity. A level of 4 corresponds to
an intensity of ~3metabolic equivalents (26). In addition, total
step count (steps per day) was recorded and calculated from
the accelerometer using computerized software (Lifelyzer 05
Coach; Suzuken Co Ltd).
Study design. Each participant underwent three, 1-d
laboratory-based trials in a randomized, counterbalanced or-
der: 1) control, 2) continuous walking, and 3) multiple short
bouts of walking. The interval between trials was 7–8 d. A
schematic illustration of the study protocol is shown in Figure 1.
Participants reported to the laboratory at 0745 h after a 10-h
overnight fast (no food or drink except water). After a 15-min
rest, a fasting venous blood sample was collected in a seated
position by venipuncture at 0800 h. On all trials, participants
were then fed a standardized meal for breakfast. For the
control trial, participants then sat in a chair (reading, writing,
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working at a computer, or watching television) in the labo-
ratory until 1600 h. For the continuous walking trial, partici-
pants rested for 40 min after breakfast before walking briskly
for 30 min in the morning from 0900 to 0930 h and were then
seated for the remainder of the trial. For the multiple short
bouts of walking trial, participants rested for 40 min after
consuming breakfast before performing twenty, 1.5-min bouts
of brisk walking on a treadmill throughout the day. During
each trial, participants consumed a standardized first test meal
for breakfast after collecting the fasting blood samples by
venipuncture. A clock was started when participants began
eating. A second test meal was consumed for lunch 3 h after
the initiation of the first meal. Further venous blood samples
were collected by venipuncture at 2 h (1000 h), 4 h (1200 h),
6 h (1400 h), and 8 h (1600 h) after the initiation of breakfast
for the measurement of circulating concentrations of TG,
nonesterified fatty acids (NEFA), acetoacetic acids, total ke-
tone bodies, apo B-48, apo B-100, preheparin LPL, glucose,
and insulin.
Exercise. On both exercise trials, the speed of walking
was at a self-selected pace as determined by the preliminary
visit. For the continuous walking trial, participants walked
briskly for 30 min in the morning from 0900 to 0930 h. For
the multiple short bouts of walking trial, participants walked
on a treadmill throughout the day at 0900, 0915, 0930, 0945,
1015, 1030, 1045, 1215, 1230, 1245, 1300, 1315, 1330,
1345, 1415, 1430, 1445, 1500, 1515, and 1530 h. The
spacing of the walks was every 15 min with three longer
breaks to allow for blood sampling and consumption of a
lunch. This timing was chosen because we have shown that
a similar pattern of walking can reduce postprandial TG in
healthy, postmenopausal women (11). Moreover, longer but
less frequent bouts of regular activity, taken the previous or
same day as high-fat or mixed meals have been consumed,
can mitigate postprandial TG concentrations (11,14,15).
Heart rate was monitored throughout both walking trials
using short-range telemetry (Polar RS400; Polar Electro Oy,
Espoo, Finland), and ratings of perceived exertion (RPE)
were assessed periodically (27). Except for prescribed walk-
ing and toilet breaks, all trials followed the same format with
participants seated throughout.
Test meals. A continental breakfast was provided as
the first meal and consisted of white bread with butter, a
salad (made of lettuce, tomato, and ham with an Italian
dressing), scrambled egg (one egg with tomato ketchup and
soybean oil), soup (made of whole milk with corn soup
powder), apple, and yogurt. It provided 0.34 g fat, 1.13 g
carbohydrate, 0.35 g protein, and 38 kJ energy per kilogram
of body mass. Mean macronutrient content of the break-
fast was 20.9 T 3.8 g fat, 69.5 T 12.6 g carbohydrate, and
21.5 T 3.9 g protein, which provided 2.3 T 0.4 MJ energy
(35% from fat, 50% from carbohydrate, and 15% from pro-
tein). The test lunch consisted of a typical Japanese fish dish
(made from grilled salmon), a bowl of white rice, soup (made
with soybean curd, seaweed, soybean paste, and deep-fried
soybean curd), and steamed vegetables (cabbage, carrot, cu-
cumber, potato, and broccoli with a mayonnaise dressing)
with ham and a cream cracker. It provided 0.34 g fat, 1.13 g
carbohydrate, 0.35 g protein, and 38 kJ energy per kilogram
of body mass. Mean macronutrient content of the lunch was
21.5 T 3.9 g fat, 67.6 T 12.2 g carbohydrate, and 20.9 T 3.8 g
protein, which provided 2.3 T 0.4 MJ energy (35% from fat,
50% from carbohydrate, and 15% from protein). Participants
were asked to consume each test meal within 30 min, and
consumption time was recorded and replicated in subsequent
trials. Mean time to consume breakfast and lunch was 16.1 T
2.6 and 16.8 T 2.1 min, respectively. None of the participants
reported nausea or any gastrointestinal discomfort during
or after either meal. Participants consumed water ad libitum
during the first trial, and the pattern and volume ingested
was replicated in subsequent trials. Average water intake was
783 T 281 mL over 8 h.
Analytical methods. For serum TG, NEFA, acetoacetic
acids, and total ketone body measurements, venous blood
samples were collected into tubes containing clotting activa-
tors for isolation of serum. Thereafter, samples were allowed
to clot for 30 min at room temperature and then centrifuged
at 1861g for 10 min at 4-C. Serum was removed, divided into
aliquots, and stored at j80-C for later analysis. For plasma
apo B-48, apo B-100, preheparin LPL, and insulin measure-
ments, venous blood samples were collected into tubes contain-
ing dipotassium salt–EDTA. For plasma glucose measurements,
venous blood samples were collected into tubes containing
sodium fluoride–EDTA. Thereafter, both tubes were imme-
diately centrifuged and treated as previously mentioned. En-
zymatic, colorimetric assays were used to measure serum TG
(Pure Auto S TG-N; Sekisui Medical Co Ltd, Tokyo, Japan),
serum NEFA (NEFA-HR; Wako Pure Chemical Industries,
Ltd, Osaka, Japan), serum acetoacetic acid (KAINOS 3-HB;
Kainos Laboratories, Inc, Tokyo, Japan), serum total ketone
FIGURE 1—A schematic representation of the study protocol. For the
control trial, participants sat in a chair (reading, writing, working at a
computer, or watching television) in the laboratory until 1600 h. For the
continuous walking trial, participants rested for 40 min after breakfast
before walking briskly for 30 min in the morning from 0900 to 0930 h
and were then seated for the remainder of the trial. For the multiple
short bouts of walking trial, participants rested for 40 min after con-
suming breakfast before performing twenty, 1.5-min bouts of brisk
walking on a treadmill throughout the day.
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bodies (KAINOS TKB-L; Kainos Laboratories, Inc), and plasma
glucose (GLU-HK(M); Shino-Test Corporation, Kanagawa,
Japan). Enzyme-linked immunosorbent assays (ELISA) were
used to measure plasma insulin (Mercodia Insulin ELISA;
Mercodia AB, Uppsala, Sweden), apo B-48 (Human Apo B-48
ELISA; Shibayagi, Ishihara, Japan), apo B-100 (Human ApoB-
100 assay kit; IBL, Gunma, Japan), and preheparin LPL (Li-
poprotein lipase ELISA; Cell Biolabs, Inc, San Diego, CA). All
analyses for each participant were completed within the same
run for each measure. Intra-assay coefficients of variation
were 0.3% for TG, 0.8% for NEFA, 1.5% for acetoacetic
acids, 1.4% for total ketone bodies, 6.3% for apo B-48, 3.5%
for apo B-100, 7.3% for preheparin LPL, 2.8% for insulin, and
0.4% for glucose.
Calculations and statistical analysis. Data were
analyzed using the Predictive Analytics Software (PASW)
version 23.0 for Windows (SPSS Japan Inc, Tokyo, Japan).
The Shapiro–Wilk test was used to check for normality of
distribution, and all parameters were found not to differ
significantly from normal. Eight-hour total area under the
serum or plasma concentration versus time curves (AUC)
were calculated using the trapezium rule. The incremental
AUC values were calculated using the same method after
correcting for fasting (0 h) concentrations. Repeated-measures
one-factor ANOVA was used to examine differences among
the three trials for fasting serum or plasma concentrations,
AUC values, and dietary and physical activity data. Repeated-
measures two-factor ANOVA was used to examine differences
among the three trials over time for serum or plasma constit-
uents. Repeated-measures generalized estimating equations
were used to adjust for potential confounding covariates (i.e.,
fasting serum TG concentrations and the step counts recorded
the day before each main trial) when examining differences
among the three trials for the TG total and incremental AUC
values and to adjust for the influence of step counts on sec-
ondary outcome measures from serum and plasma. Where
significant interactions were detected, post hoc multiple
comparisons were made using the Bonferroni method. The
95% confidence intervals (CIs) for the mean absolute
pairwise differences between trials were calculated using
the t-distribution and degrees of freedom (n j 1). Absolute
standardized effect sizes (ES) are provided to supplement
the findings. Statistical significance was accepted at the 5%
level. Results are reported as mean T SD.
RESULTS
Dietary data. Energy intake for the day before the trials
was 7.1 T 1.1 MJ. Energy intake equated to 27% T 17%
(54.1 T 36.2 gIdj1) from fat, 55% T 15% (222.1 T 67.5 gIdj1)
from carbohydrate, and 18% T 6% (66.6 T 18.2 gIdj1) from
protein.
Accelerometer data. The step counts recorded the day
before the trials differed significantly among trials (7264 T
2944 vs 9523 T 4557 vs 9659 T 2425 steps per day for the
control, continuous walking, and multiple bouts of walking
respectively; ES = 0.289, P = 0.033), but subsequent post hoc
tests did not reveal where the between-trial differences were.
For the day before each main trial, accelerometer recorded
frequencies for light (levels 1–3; 55 T 24 vs 59 T 32 vs 68 T
21 minIdj1 for the control, continuous walking, and multiple
bouts of walking, respectively; ES = 0.202, P = 0.084),
moderate (levels 4–6; 19 T 13 vs 33 T 26 vs 27 T 19 minIdj1
for the control, continuous walking, and multiple short bouts
of walking, respectively; ES = 0.242, P = 0.063), and vigorous
(levels 7–9; 1 T 1 vs 2 T 2 vs 1 T 1 minIdj1 for the control,
continuous walking, and multiple bouts of walking, respec-
tively; ES = 0.065, P = 0.477) activity did not differ signifi-
cantly, although values for light and moderate activity tended
to be higher on the exercise trials than on the control trial.
Responses during brisk walking. Self-selected brisk
walking speed during the walking trials was 3.6 T 0.2 kmIhj1.
The mean heart rate and RPE were significantly higher on
the continuous walking trial (heart rate, 106 T 14 bpm; RPE,
12 T 2) than on the multiple short bouts of walking trial
(heart rate, 92 T 11 bpm; RPE, 11 T 1; heart rate: 95% CI,
10–18 bpm (ES = 1.158; P G 0.001); RPE: 95% CI, 0.6–3.0
(ES = 1.099, P = 0.008)).
Fasting serum/plasma concentrations. Fasting plasma
and serum concentrations for each trial are shown in Table 1.
One-factor ANOVA revealed that there was a significant
difference among trials in fasting serum TG (P = 0.022).
Subsequent post hoc tests did not reveal where the between-
trial difference in fasting TG occurred (control vs continuous
walking, P = 0.208; short bouts of walking vs control, P =
0.073; continuous walking vs short bouts of walking, P =
1.000). For fasting serum NEFA, acetoacetic acid, total ke-
tone bodies, and plasma apo B-48, apo B-100, preheparin
LPL, insulin, and glucose concentrations, there were no sig-
nificant differences among trials.
TABLE 1. Fasting concentrations of TG, NEFA, acetoacetic acids, total ketone bodies, apo B-48, apo B-100, preheparin LPL, insulin, and glucose during the control, continuous walking,
and multiple short bouts of walking trials (n = 12).
Trial Control Continuous Walking Short Bouts of Walking P
TG, mmolILj1 2.5 T 1.4 1.9 T 0.9 1.8 T 1.8 0.022
NEFA, mmolILj1 0.7 T 0.4 0.8 T 0.4 0.8 T 0.3 0.563
Acetoacetic acid, mmolILj1 0.01 T 0.01 0.02 T 0.01 0.02 T 0.01 0.181
Total ketone bodies, mmolILj1 0.06 T 0.04 0.06 T 0.03 0.07 T 0.04 0.802
Apo B-48, KgImLj1 13.6 T 13.6 9.6 T 8.3 7.1 T 5.9 0.130
Apo B-100, KgImLj1 9.2 T 1.7 10.0 T 2.6 9.3 T 1.4 0.110
Preheparin LPL, ngImLj1 209.5 T 99.2 268.9 T 183.7 240.4 T 167.9 0.554
Glucose, mmolILj1 5.8 T 1.1 6.0 T 1.2 5.9 T 1.2 0.089
Insulin, pmolILj1 41.9 T 19.4 43.3 T 17.2 44.3 T 15.5 0.737
Values are means T SD. Means were compared using one-factor ANOVA for the main effect of trial followed by a Bonferroni multiple-comparison test.
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Postprandial serum/plasma concentrations. Serum
TG concentrations during each trial are shown in Figure 2.
Serum TG concentrations differed significantly among trials
(main effect of trial: ES = 0.465, P = 0.001), with post hoc
tests indicating lower TG concentrations during the multiple
bouts (95%CI,j2.228 toj0.181 mmolILj1; ES = 0.763; P =
0.021) and continuous (95%CI,j2.043 toj0.221 mmolILj1;
ES = 0.707; P = 0.015) walking trials compared with the
control trial. There were no significant differences in serum
TG concentrations between walking trials (95% CI, j0.558
to 0.703 mmolILj1; ES = 0.064; P = 1.000). For all trials, TG
concentrations increased over the morning, peaking at 4 h
after breakfast before falling in the afternoon (main effect of
time: ES = 0.656, P G 0.001). However, the rate of increase in
TG was greater on the control trial than on the walking trials
during the first 4 h (trial–time interaction: ES = 0.262, P =
0.036). Subsequent post hoc tests revealed that TG was
greater on the control trial than on the multiple bouts and
continuous walking trials 4, 6, and 8 h after breakfast.
The TG total AUC (Fig. 3) differed among trials (ES =
0.474, P = 0.001) and was 30% and 28% lower on the
multiple short bouts of walking (95% CI, j18.024 to
j1.596 mmol per 8 hILj1; ES = 0.781; P = 0.019) and the
continuous walking (95% CI, j16.541 to j2.102 mmol per
8 hILj1; ES = 0.734; P = 0.012) trials than on the control trial,
respectively. Similarly, the incremental AUC was 33% and
35% lower on the multiple short bouts of walking (95% CI,
j7.966 toj0.535 mmol per 8 hILj1; ES = 0.762; P = 0.024)
and the continuous walking (95%CI,j7.566 toj1.570 mmol
per 8 hILj1; ES = 0.984; P = 0.004) trials than on the control
trial, respectively. Because physical activity can potentially
affect TG outcomes for 24–48 h, we examined the rela-
tionship between measures of physical activity on the day
before each main trial, which differed among trials, and the
TG total and incremental AUC on all trials. No significant
correlation was seen for step counts (r = j0.157, P = 0.360),
or time spent in light (r = j0.014, P = 0.933), moderate (r =
j0.237, P = 0.171), or vigorous (r = j0.106, P = 0.539)
physical activity with TG total AUC. A similar finding was
seen for the relationships between step counts, and light and
vigorous physical activity with TG incremental AUC (all
P 9 0.1), although moderate physical activity did tend to
be negatively associated with incremental AUC (r = j0.323,
P = 0.058). When moderate physical activity was placed into
a linear regression, however, it did not significantly explain
any proportion of the TG incremental AUC (P = 0.116).
Furthermore, generalized estimating equations for the TG
total AUC after adjusting for fasting TG concentrations
differed among trials (P G 0.001) and were lower on the multiple
short bouts of walking (95% CI, j16.5 to j3.1 mmol per
8 hILj1; P = 0.001) and the continuous walking (95% CI,
j15.2 to j3.5 mmol per 8 hILj1; P G 0.001) trials than on
the control trial. Similarly, the TG incremental AUC was
lower on the multiple short bouts of walking (95% CI,j7.3 to
j1.2mmol per 8 hILj1; P = 0.002) and the continuous walking
(95% CI, j7.0 to j2.1 mmol per 8 hILj1; P G 0.001) trials
than on the control trial. These findings were also confirmed
by the generalized estimating equation analysis after adjusting
for the step counts recorded the day before each main trial
(data not shown).
The 8-h total and incremental AUC values for NEFA,
acetoacetic acid, total ketone bodies, apo B-48, apo B-100,
preheparin LPL, insulin, and glucose are shown in Table 2.
For acetoacetic acids, total AUC was greater on the contin-
uous walking trial compared with the control trial (P = 0.014).
In a similar manner, total ketone body AUC concentrations
were higher on the continuous walking trial than on the
control trial (P = 0.032). The 8-h total glucose concentrations
were greater on the continuous walking trial than on the con-
trol (P = 0.007) or multiple short bouts of walking (P = 0.016)
trials. The NEFA, apo B-48, apo B-100, preheparin LPL, and
insulin total and incremental AUC values did not differ
FIGURE 2—Fasting and postprandial serum TG concentrations during
the control, continuous walking, andmultiple short bouts of walking trials
(n = 12). Data are means T SD. The black arrows indicate the times that
the test meals were consumed. Data were analyzed using two-factor
ANOVA followed by a Bonferroni multiple-comparison test. There was a
significant main effect of trial (P = 0.001), main effect of time (P G 0.001),
and trial–time interaction (P = 0.036). *Significantly different from the
short bouts of walking and continuous walking trials, P G 0.05.
FIGURE 3—Serum TG total (AUC)/incremental area under the curve
(iAUC) values over 8 h after the consumption of the test meals in the
control, continuous walking, and multiple short bouts of walking trials
(n = 12). Data are means T SD. Means were compared using one-factor
ANOVA for the main effect of trial followed by a Bonferroni multiple-
comparison test. *Significantly different from the control, P G 0.05.
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among the trials. The use of generalized estimating equations
adjusting for the influence of step counts on these AUC
measures did not change these differences.
DISCUSSION
The present study is, to our knowledge, the first to com-
pare how different patterns of brisk walking influence serum
TG in postmenopausal, older women with hypertriglyc-
eridemia. Our findings indicate that accumulating 30 min
of brisk walking in short (1.5 min) bouts is as effective in
attenuating postprandial TG concentrations as the same
volume of exercise taken in a continuous pattern. These
findings support previous observations from studies in healthy
adults (9,10,12) and add to a growing body of evidence sub-
stantiating public health recommendations on accumulating
physical activity for health (1,3,28). Moreover, our study de-
sign is supportive of the many emerging studies that show the
benefit of interrupting sedentary time with regular activity
breaks on improved glycemic control over a day (19–22)
(for a review of these, see Ref. [29]). The present study is
one of few to demonstrate a beneficial effect on same-day
postprandial TG excursions (11,12,21), and the observation
is important because potentially postprandial glucose and
TG control might be achieved in tandem.
We found comparable reductions in the TG incremental
AUC over 8 h with either twenty, 1.5-min bouts of brisk
walking (33%) or one, 30-min bout of brisk walking (35%)
of equal intensity in older women with hypertriglyceridemia.
Our findings are consistent with previous studies employing
active young (9,10) and sedentary middle-age individuals
(7,12). Moreover, our data corroborate experimental studies
and meta-analyses that demonstrate that the energy expen-
diture of exercise is the primary determinant of the extent of
exercise-induced reductions in postprandial TG (24) irre-
spective of the pattern of exercise. Our data are of value in
showing that short bouts of physical activity accumulated
throughout a day could provide additional benefit to
cardiovascular disease risk factors. In addition, given that
high levels of physical activity seem to eliminate the increased
risk for death associated with high sitting time (18), our data
may imply that increased regular physical activity irrespective
of the pattern of exercise could beneficially modify disease
risk markers.
The reduction of postprandial TG concentrations after
exercise observed in the present study may have been me-
diated via several mechanisms. One is increased muscle LPL
activity, which is a major factor for the removal of TG from
the circulation (30). However, no differences in circulating
concentrations of inactive monomeric LPL or insulin, which
can suppress LPL activity in skeletal muscle, were observed
among the three trials. Thus, the single-day design of the
present study may have meant that increases in LPL activity
in the two exercise trials were not yet apparent because the
activity of this enzyme is thought not to peak until Q8 h after
exercise (30). Rather, the sitting on the control trial may
have been more important in our study because observations
in rats have shown 10- to 20-fold decreases in LPL activity
in red oxidative muscle and 50% decreases in white glyco-
lytic muscle, which begin to occur within 4–6 h of initiating
inactivity (31). These alterations in LPL activity occur without
any change in the messenger RNA expression of the en-
zyme, and the time course of 4–6 h is well within that of the
present experiment.
Alternatively, more recently, it has been proposed that
reductions in VLDL-TG result from improved clearance from
the circulation after exercise, because these particles be-
come TG enriched increasing their affinity for LPL–mediated
hydrolysis (32). This mechanism may have been present
here, but our assays were unable to distinguish changes in
the size of VLDL particles and did not directly measure LPL
activity but rather concentration. A final possibility is that
increases in circulating blood flow may also have enhanced
TG clearance by increasing the exposure of LPL to circulating
TG in lipoproteins (12), a mechanism that may be of more
importance in a 1- than 2-d design.
TABLE 2. Serum NEFA, acetoacetic acids, total ketone bodies, apo B-48, apo B-100, preheparin LPL, and plasma insulin, and glucose total (t) and incremental (i) area AUC values over 8 h
after the consumption of the test meals in the control, continuous walking, and multiple short bouts of walking trials (n = 12).
Trial Control Continuous Walking Short Bouts of Walking P
NEFA tAUC, mmolILj1 per 8 h 3.3 T 1.4 4.0 T 1.8 3.6 T 1.4 0.078
NEFA iAUC, mmolILj1 per 8 h 0.7 T 0.4 0.7 T 0.5 0.7 T 0.6 0.828
Acetoacetic acid tAUC, mmolILj1 per 8 h 0.10 T 0.03 0.14 T 0.04* 0.13 T 0.04 0.013
Acetoacetic acid iAUC, mmolILj1 per 8 h 0.07 T 0.03 0.07 T 0.05 0.05 T 0.04 0.335
Total ketone bodies tAUC, mmolILj1 per 8 h 0.28 T 0.07 0.34 T 0.09* 0.32 T 0.06 0.040
Total ketone bodies iAUC, mmolILj1 per 8 h 0.05 T 0.05 0.07 T 0.12 0.06 T 0.10 0.706
Apo B-48 tAUC, KgImLj1 per 8 h 200.5 T 187.8 143.7 T 86.6 122.9 T 77.2 0.154
Apo B-48 iAUC, KgImLj1 per 8 h 100.4 T 132.1 75.4 T 20.1 66.9 T 53.8 0.344
Apo B-100 tAUC, KgImLj1 per 8 h 72.6 T 12.0 72.8 T 15.0 74.2 T 11.8 0.110
Apo B-100 iAUC, KgImLj1 per 8 h 27.4 T 25.6 7.4 T 11.6 22.9 T 31.9 0.120
Preheparin LPL tAUC, ngImLj1 per 8 h 1625.6 T 559.3 1948.8 T 895.4 1854.3 T 994.3 0.201
Preheparin LPL iAUC, ngImLj1 per 8 h 646.8 T 648.4 563.3 T 629.4 808.0 T 1024.1 0.750
Glucose tAUC, mmolILj1 per 8 h 49.2 T 9.8 54.1 T 11.1*,** 51.0 T 9.6 G0.001
Glucose iAUC, mmolILj1 per 8 h 33.1 T 12.2 39.2 T 16.2 30.9 T 15.6 0.241
Insulin tAUC, pmolILj1 per 8 h 1184.6 T 560.9 1138.2 T 423.1 1107.7 T 410.7 0.717
Insulin iAUC, pmolILj1 per 8 h 849.3 T 439.5 791.6 T 336.5 753.0 T 308.8 0.579
Values are means T SD. Means were compared using one-factor ANOVA for the main effect of trial followed by a Bonferroni multiple-comparison test.
*Significantly different from the control trial, P G 0.05.
**Significantly different from the short bouts of walking trial, P G 0.05.
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Another potential mechanism for the TG reductions seen
during the exercise trials is reduced secretion of hepatic
VLDL (33). Postprandial apo B-100 concentrations did not
differ among the three trials but total ketone bodies (a
marker for hepatic fatty acid oxidation), including acetoacetic
acids, were elevated, particularly with continuous exercise.
Thus, hepatic fatty acid availability for incorporation into
VLDL-TG may have been reduced with exercise. An alter-
native explanation is that postprandial exercise impeded or
slowed the entry of chylomicrons into the circulation because
the rate of increase in TG concentrations was greater in the
first 4 h after breakfast in the control trial. However, post-
prandial apo B-48 concentrations did not differ among the
three trials in the present study, which is consistent with
previous observations measuring TG concentrations directly
in the chylomicron fraction with exercise (34).
In contrast to TG reductions with both patterns of walking
and in contrast with many recent studies (19–22), there were
no improvements in postprandial glucose or insulin. It is
worth noting that the glucose total AUC was greater in the
continuous walking trial than in the short bouts of walking
and control trials in the present study, a similar observation
to our previous study in healthy postmenopausal women
who completed the same exercise protocol (11). It is likely
that when exercise is performed in the postprandial state that
rates of glucose appearance from both exogenous and en-
dogenous sources supersede the rate of glucose clearance
into muscle and that glycemic responses to second meals
are elevated, a phenomenon documented by others (35).
This phenomenon may be part adrenaline-induced hyper-
glycemia, which can occur with prolonged or intense exer-
cise (36). Indeed, higher mean HR and RPE were observed
in the continuous walking than in the short bouts of walking
trial in the present study. Thus, brisk walking for 30 min
continuously may be harder exercise than accumulating the
same amount of walking in these inactive, older individuals.
Other studies that interrupted sitting time with short bouts
of light- or moderate-intensity exercise (e3 min) have found
that exercise during the postprandial period attenuates post-
prandial glucose and insulin (21,22,25). The discrepancy
among studies (21,22,25) may be partly explained by the
genetic background of the participants because we studied
Japanese participants, whereas all other studies have exam-
ined participants from Western countries (21,22,25). East
Asians have been shown to have limited innate capacity for
insulin secretion compared with Caucasians (37). This is
similar to other Asian populations, such as South Asians,
who have lower insulin sensitivity than Europeans (38).
Thus, carbohydrate metabolism in response to exercise may
differ between ethnic groups.
This study has several strengths. First, we examined post-
menopausal, older women with hypertriglyceridemia, where-
as few previous studies examining the effects of exercise on
TG have employed at-risk older adults (24). Perturbations in
TG concentrations after meals are more likely to be exag-
gerated in such individuals compared with their healthy
younger peers (39). Second, Asian (Japanese) women were
employed in the present study. The effects of exercise on
postprandial TG have been studied less frequently in women
than in men, perhaps because of the need to control for the
menstrual cycle in premenopausal women. Moreover, most
studies examining the effects of exercise on postprandial TG
have employed populations of white European descent (for a
review of these, see Ref. [15]) with only a small number of
studies in Asians (8,11,40). A recent review suggests that
while nonwhite populations do receive health benefit from
increased physical activity levels, the ideal physical activity
required to lower cardiometabolic disease risk may differ by
ethnic group (41). Indeed, South Asians require a greater
amount of physical activity to gain a similar cardiometabolic
risk profile to that of individuals of white European descent
(42). At least two studies have directly examined this issue
for postprandial TG. Although there was a greater elevation
in TG after meals in South Asian than in white European
men (43,44), acute exercise was equally effective for re-
ducing TG concentrations in both populations (43) and the
extent of the reduction may be even greater in South Asians
than in white Europeans (44). No similar comparison has
been made with individuals of East Asian origin that we are
aware of. Thus, future studies should better characterize the
TG responses to exercise in different ethnic groups. Third,
although the investigation of the mechanism underlying
exercise-induced reductions in postprandial TG was not our
primary purpose, we examined various markers of post-
prandial TG metabolism, including acetoacetic acid, apo
B-48, apo B-100, and preheparin LPL, which have not been
examined in previous studies on accumulated exercise and
postprandial TG (6–11). Finally, the magnitude of reduction
in postprandial TG observed after multiple short bouts of
exercise in the present study was large (~33%) compared
with those observed in other studies with healthy individuals
(~27%) (11–13). Although the clinical significance of our
findings is uncertain, the finding is important because such a
reduction by exercise may be equally, if not more, effective
for reducing the risk for ischemic heart disease (30%–40%)
than that seen with pharmaceutical therapy (45). Indeed, an
epidemiological study has shown that nonfasting TG con-
centrations are predictive of risk for ischemic heart disease
in Japanese men and women (4). Thus, it is feasible to
speculate that the reduction in postprandial TG observed in
the present study could have important public health impli-
cations with respect to cardiovascular disease risk.
This study has several limitations. The use of a single-day
design to compare the immediate (same-day) effect of dif-
ferent patterns of walking on postprandial TG metabolism
may have provided insufficient time for an elevation in LPL
activity as previously discussed. Another limitation is the
relatively small sample size, which may explain the lack of
statistical significance for our secondary outcomes, including
glucose and insulin. A third limitation is the standardization
of the participants’ pretrial physical activity. Although the
total and incremental TG AUC values after adjusting for
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fasting TG concentrations or the step counts recorded the day
before each main trial were lower on the multiple short bouts
of walking and the continuous walking trials than on the
control trial, differences in activity levels, including step
counts, which were higher the day before the exercise trials,
could have influenced LPL activation and therefore en-
hanced TG clearance during the walking trials.
In conclusion, 30 min of continuous brisk walking or
the same amount of walking achieved by accumulating very
short (1.5 min) bouts of walking over the course of a day
can attenuate postprandial TG concentrations in physically
inactive, postmenopausal, older women with hypertriglyc-
eridemia. These findings substantiate recommendations in
physical activity guidelines that similar health benefits can
be obtained through accumulated versus continuous activity
in at-risk older adults.
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